Yeongrin Kim

Daejeon, Republic of Korea

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 15 publications

Reversible control of CAR T cells through PROTAC compound targeting bromodomain mutant.

Reversible control of CAR T cells through PROTAC compound targeting bromodomain mutant.

Journal: Molecular therapy. Oncology
Published: February 17, 2025

Discovery of a novel envelope protein derived from simian retrovirus 2 for pseudotyping retroviral vectors used for production of CAR immune cells.

Discovery of a novel envelope protein derived from simian retrovirus 2 for pseudotyping retroviral vectors used for production of CAR immune cells.

Journal: Nature communications
Published: January 14, 2025

Lentivirus-based production of human chimeric antigen receptor macrophages from peripheral blood.

Lentivirus-based production of human chimeric antigen receptor macrophages from peripheral blood.

Journal: Biomarker research
Published: November 26, 2024

TET2 downregulation enhances the antitumor efficacy of CD19 CAR T cells in a preclinical model.

TET2 downregulation enhances the antitumor efficacy of CD19 CAR T cells in a preclinical model.

Journal: Experimental hematology & oncology
Published: October 25, 2024

Development of Genetically Engineered Feeder Cells for Natural Killer Cell Expansion.

Development of Genetically Engineered Feeder Cells for Natural Killer Cell Expansion.

Journal: Anticancer research
Published: June 23, 2023

T Cells Expressing CAR Equipped With Extracellular Domain of BTLA Are Effective Against HVEM-over-expressing Melanoma Cell Lines.

T Cells Expressing CAR Equipped With Extracellular Domain of BTLA Are Effective Against HVEM-over-expressing Melanoma Cell Lines.

Journal: Anticancer research
Published: May 23, 2023

Optimized conditions for gene transduction into primary immune cells using viral vectors.

Optimized conditions for gene transduction into primary immune cells using viral vectors.

Journal: Scientific reports
Published: March 16, 2023

Discovery of BET specific bromodomain inhibitors with a novel scaffold.

Discovery of BET specific bromodomain inhibitors with a novel scaffold.

Journal: Bioorganic & medicinal chemistry
Published: June 24, 2022

Structure-activity relationship analysis of novel GSPT1 degraders based on benzotriazinone scaffold and its antitumor effect on xenograft mouse model.

Structure-activity relationship analysis of novel GSPT1 degraders based on benzotriazinone scaffold and its antitumor effect on xenograft mouse model.

Journal: Bioorganic chemistry
Published: February 09, 2022

c-Met-Specific Chimeric Antigen Receptor T Cells Demonstrate Anti-Tumor Effect in c-Met Positive Gastric Cancer.

c-Met-Specific Chimeric Antigen Receptor T Cells Demonstrate Anti-Tumor Effect in c-Met Positive Gastric Cancer.

Journal: Cancers
Published: August 04, 2021

Synthesis and Structure-Activity Relationships of Aristoyagonine Derivatives as Brd4 Bromodomain Inhibitors with X-ray Co-Crystal Research.

Synthesis and Structure-Activity Relationships of Aristoyagonine Derivatives as Brd4 Bromodomain Inhibitors with X-ray Co-Crystal Research.

Journal: Molecules (Basel, Switzerland)
Published: February 18, 2021

Development of Antigen-specific Chimeric Antigen Receptor KHYG-1 Cells for Glioblastoma.

Development of Antigen-specific Chimeric Antigen Receptor KHYG-1 Cells for Glioblastoma.

Journal: Anticancer research
Published: February 18, 2021
Showing 1-12 of 15

Last Updated: 09/26/2026